《FDA批准的非核苷逆转录酶抑制剂：Rescriptor》

• 来源专题：艾滋病防治
• 编译者： 李越
• 发布时间：2011-11-16
• 原文来源：http://aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id=166&ClassID=3&TypeID=1

Brand Name: Rescriptor Other Name(s): 136817-59-9, DLV, Delavirdine mesylate, U-90152S Drug Class: Non-nucleoside Reverse Transcriptase Inhibitors Contains the dose and use, dosage form and route of administration, the recommended daily dosage, possible side effects.